Lidocaine Hydrochloride And Epinephrine Injection, Solution
NDC Package 0409-0147-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Lidocaine Hydrochloride And Epinephrine injection is uSP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed. This formulation utilizes a injection, solution delivery system. Marketed by Hospira, Inc., this product is identified by NDC 0409-0147 and is authorized under FDA application ANDA089646.

Identification & Billing

NDC Package Code
0409-0147-10
Package Description
10 VIAL, MULTI-DOSE in 1 CARTON / 20 mL in 1 VIAL, MULTI-DOSE (0409-0147-01)
Product Code
0409-0147
11-Digit Billing Format
00409014710
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 1010688 - lidocaine HCl 2 % / EPINEPHrine 1:200,000 in 20 ML Injection
  • RxCUI: 1010688 - 20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection
  • RxCUI: 1010688 - lidocaine HCl 2 % / EPINEPHrine 1:200,000 per 20 ML Injection
  • RxCUI: 1010745 - lidocaine HCl 0.5 % / EPINEPHrine 1:200,000 Injectable Solution
  • RxCUI: 1010745 - epinephrine 0.005 MG/ML / lidocaine hydrochloride 5 MG/ML Injectable Solution

Clinical Specifications

Proprietary Name
Lidocaine Hydrochloride And Epinephrine
Non-Proprietary Name
Lidocaine Hydrochloride And Epinephrine
Substance Name
Epinephrine; Lidocaine Hydrochloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Infiltration - Administration that results in substances passing into tissue spaces or into cells.
  • Perineural - Administration surrounding a nerve or nerves.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Lidocaine Hydrochloride and Epinephrine Injection, USP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection, by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.

Regulatory & Marketing

Labeler Name
Hospira, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA089646
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-28-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J2004
Source: PDAC
INJECTION, LIDOCAINE HCL WITH EPINEPHRINE, 1 MG
HCPCS Dosage 1 MG
Units / Pkg

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0409-0147-10 identifies a specific commercial package of 10 vial, multi-dose in 1 carton / 20 ml in 1 vial, multi-dose (0409-0147-01) of Lidocaine Hydrochloride And Epinephrine, a human prescription drug labeled by Hospira, Inc.. This injection, solution is formulated for infiltration; perineural use and contains epinephrine; lidocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hospira, Inc. on October 28, 2024. The current certification is valid through December 31, 2027.

How is this Hospira, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00409014710. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0409-0147-10
11-Digit CMS (5-4-2)
00409-0147-10

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.